Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECHO.L Regulatory News (ECHO)

  • There is currently no data for ECHO

Conversion of convertible loan notes

27 May 2016 14:56

RNS Number : 5794Z
Independent Resources PLC
27 May 2016
 

FOR IMMEDIATE RELEASE

 

27 May 2016

 

Independent Resources plc

("IRG" or the "Company") 

Conversion of convertible loan notes

IRG announces that today it exercised its option to repay through the issue of new ordinary shares of 0.01p each in the Company ("Shares"), the outstanding principal of £200,000 and accrued interest of £17,143 due on its issue of convertible loan notes ("CUL's"), announced to the market on 17 May 2016.

Pursuant to the terms of the CUL's, 452,380,952 Shares ("Repayment Shares") have been issued at a price of 0.048p per Share ("Conversion Price"), being the average of the three lowest closing mid-market prices of the Company's Shares between the issue date of the CUL's and the Company notifying the holders of the CUL's of IRG's intention to repay the CUL's in Shares, less a price discount of 10 per cent.

The Directors consider that it is in the best interests of the Company and its shareholders to repay the CULs with immediate effect through the issue of new equity thereby avoiding further material interest payments accruing and retaining cash within the Company.

Further, as announced to the market on 23 May 2016, a trade creditor has agreed to accept payment of indebtedness of £36,000 through the issue of Shares at the Conversion Price. Pursuant to this agreement the Company will issue 75,000,000 Shares to this creditor ("Creditor Shares").

Following the issue of the Repayment Shares and Creditor Shares referred to above and the 69,428,571 Shares expected to be admitted to trading on 1 June 2016 pursuant to the arrangements announced on 25 May 2016, there will be 1,262,504,294 ordinary shares of 0.01p each in the Company in issue. The figure of 1,262,504,294 Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the Disclosure and Transparency Rules.

The Repayment Shares and the Creditor Shares will rank pari passu with the Company's existing ordinary shares of 0.01p each. Application will be made for the Repayment Shares and the Creditor Shares to be admitted to trading on AIM ("Admission").

It is expected that Admission will become effective and dealings in the Repayment Shares and the Creditor Shares will commence at 8.00 a.m. on 3 June 2016.

CEO comment

Commenting on the repayment of the CUL's and their conversion into equity Greg Coleman, CEO of Independent Resources said:

"The Company remains committed to conserving its cash and improving its liquidity and both these objectives are served by our decision to repay the outstanding principal and accrued interest on the Company's convertible loan notes through the issue of equity."

For more information, please visit www.ir-plc.com or contact:

Greg Coleman

Independent Resources plc

020 3367 1134

Adam James

Panmure Gordon (UK) Limited

020 7886 2500

(Nominated Adviser & Joint Broker)

Oliver Stansfield

Brandon Hill Capital

020 3463 5000

Jonathan Evans

(Joint Broker)

Simon Hudson

Tavistock Communications

020 7920 3150

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRBXGDUXUDBGLR
Date   Source Headline
4th Aug 20177:00 amRNSInterim Results 2017
2nd Aug 20174:00 pmRNSExercise of Warrants
1st Aug 20171:20 pmRNSTotal Voting Rights
31st Jul 20177:00 amRNSBroker Change
26th Jul 201711:25 amRNSSignature of a Technical Evaluation Agreement
21st Jul 201712:36 pmRNSAdmission of Shares
20th Jul 20172:00 pmRNSFurther re: Directorate Change
7th Jul 201711:31 amRNSInvestor Call/PDMR Shareholding/Regulatory Update
5th Jul 20177:00 amRNSBoard Appointment
5th Jul 20177:00 amRNSQ3 Portfolio Update
3rd Jul 20174:48 pmRNSTotal Voting Rights
27th Jun 201712:49 pmRNSBond Listing
27th Jun 201711:46 amRNSResult of AGM and Director/PDMR Shareholding
27th Jun 20177:00 amRNSAppointment of CFO
23rd Jun 20176:26 pmRNSHolding(s) in Company
23rd Jun 20173:37 pmRNSHolding(s) in Company
21st Jun 20177:00 amRNSBolivian Market Entry
16th Jun 20172:45 pmRNSHolding(s) in Company
15th Jun 20177:00 amRNSEgypt Divestment
13th Jun 20177:00 amRNSCompletion of £10,000,000 Subscription
12th Jun 20177:00 amRNSAppointment of CEO and VP Exploration
9th Jun 20178:12 amRNSNotice of AGM
6th Jun 20178:51 amRNSHolding(s) in Company
1st Jun 20174:05 pmRNSAudited results year ended 31 December 2016
1st Jun 20177:00 amRNSHolding(s) in Company
31st May 20174:28 pmRNSTotal Voting Rights
30th May 20177:00 amRNSFurther Institutional Funding
25th May 201711:00 amRNSCompletion of Debt Facility
22nd May 20171:42 pmRNSResult of General Meeting
22nd May 20177:00 amRNSHolding(s) in Company
19th May 20173:40 pmRNSSignature of £10,000,000 Institutional Placing
15th May 20177:00 amRNSSignature of First Institutional Funding
5th May 20177:00 amRNSCirc re. allotment authorities and consolidation
2nd May 20171:27 pmRNSTotal Voting Rights
25th Apr 201711:07 amRNSHolding(s) in Company
21st Apr 20174:56 pmRNSHolding(s) in Company
18th Apr 20174:09 pmRNSResult of GM & Successful Conclusion of Open Offer
18th Apr 20177:00 amRNSStrategy, Conditional Funding, Share Consolidation
30th Mar 20173:13 pmRNSBlock Admission, Warrant Exercise and TVR
28th Mar 20177:00 amRNSDirector Appointment Confirmed
24th Mar 201711:37 amRNSWarrant Exercise and Total Voting Rights
20th Mar 201712:59 pmRNSWarrant Exercise and Total Voting Rights
16th Mar 20177:00 amRNSPosting of Circular
14th Mar 20177:00 amRNSOpen Offer, Warrant Exercise, Director Resignation
10th Mar 20171:41 pmRNSHolding(s) in Company
9th Mar 20172:16 pmRNSHolding(s) in Company
8th Mar 20177:00 amRNSHolding(s) in Company & Update on Open Offer
6th Mar 20177:00 amRNSBoard Changes/Investment/Open Offer & Name Change
1st Feb 20179:50 amRNSIssue of Equity
9th Dec 201612:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.